{"podcast":{"title":"Seattle News Today | 2 Min News | The Daily News Now!","slug":"seattle-news-today-2-min-news-the-daily-news-now-7463302","podcast_index_feed_id":7463302,"rss_url":"https://feeds.fastcast.ai/the-seattle-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-seattle-daily-news-now.jpg","author":"The Daily News Now!","episode_count":1989,"summary":"Hosted by Corey with the Story, Seattle News Today delivers daily coverage of everything happening in Seattle with fast, focused updates on local news, government, business, public safety, weather, and the stories shaping the city. From tech developments to regional issues, the show keeps you informed on what matters most across Seattle. Each short episode highlights what matters most—including key updates, local trends, and stories shaping the city—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Seattle News Today is built for listeners who want reliable local news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-31T14:17:26.305386+00:00","page_url":"https://stenobird.com/podcast/seattle-news-today-2-min-news-the-daily-news-now-7463302"},"episode":{"title":"FDA Peptide Review Sparks Legal Battle | Seattle News","slug":"fda-peptide-review-sparks-legal-battle-seattle-news","published_at":"2026-07-11T01:10:20+00:00","page_url":"https://stenobird.com/podcast/seattle-news-today-2-min-news-the-daily-news-now-7463302/fda-peptide-review-sparks-legal-battle-seattle-news","show_page_url":"https://stenobird.com/podcast/seattle-news-today-2-min-news-the-daily-news-now-7463302","url":"https://sources.thednn.ai/b12fb4dbc28870df","audio_url":"https://api.fastcast.ai/audio/35c26b82-a033-4c4f-833f-b74f9d6bd48c.mp3","summary":"The FDA is reviewing a list of 17 compounded peptides—key amino acid chains that help regulate everything from sleep to inflammation—and could soon restrict their availability, sparking a legal battle from EVEXIAS Life Sciences. Patients relying on these custom treatments for chronic conditions may lose access if the ban sticks. Experts urge caution against unregulated online peptide mixes, warning of contamination and dosage risks. The FDA’s final call could reshape the future of personalized wellness therapies. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/b12fb4dbc28870df","meta_description":"The FDA is reviewing a list of 17 compounded peptides—key amino acid chains that help regulate everything from sleep to inflammation—and could soon restri…","key_points":[],"chapters":[],"topics":[],"duration_seconds":82,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/seattle-news-today-2-min-news-the-daily-news-now-7463302/episodes/fda-peptide-review-sparks-legal-battle-seattle-news/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/seattle-news-today-2-min-news-the-daily-news-now-7463302/fda-peptide-review-sparks-legal-battle-seattle-news.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}